Skip to main content
Caplight Logo









Graviton BioScience

Graviton BioScience

Private
New York City, New YorkHealthcare & Life Scienceshttps://graviton.bio/

Last Round

Series B

Feb 14, 2024

Est. Valuation

$255M

Total Funding Raised

$63.5M

Company Overview

Graviton BioScience is a biotechnology company that discovers and develops innovative small-molecule therapeutics for autoimmune, cancer, fibrotic, and central nervous system diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyROCK2 inhibitorsmall-molecule therapeuticsdrug discoveryclinical-stage biotechfibrotic diseaseautoimmune diseasemetabolic diseaseCNS disordersdrug licensingblood-brain barrierpharma partnershipbiotech startupdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Graviton BioScience Comparables

Compare Graviton BioScience with similar companies based on industry and business-model similarity.

Graviton BioScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ovid Therapeutics Inc.
82%
Genosco
81%
Sino Biopharmaceutical
78%

Graviton BioScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 14, 2024
Series BNov 22, 2023
Series AMay 1, 2023
SeedFeb 19, 2021

Graviton BioScience Investors

Notable investors and investment history

Graviton BioScience investors
InvestorRounds
Enavate SciencesSeries A, Series B
Cormorant Asset ManagementSeries A
Pontifax Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 60% MoM, from 1.1K to 1.7K.

  • Nov 11, 2025

    Monthly visitors grew 41% MoM.

Graviton BioScience Filings

Explore SEC and related filing metadata, where available.

Graviton BioScience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Graviton BioScience's valuation, stock price, and market status.

Is Graviton BioScience a public or private company?

Graviton BioScience is a private company.

What is the current stock price of Graviton BioScience?

Graviton BioScience is a private company with no public stock price. No recent secondary market data is available.

How much is Graviton BioScience worth (valuation)?

Valuation information for Graviton BioScience is not publicly available.

Can I buy Graviton BioScience stock?

Graviton BioScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Graviton BioScience's last funding round?

Graviton BioScience's most recent funding round was Series B on November 22, 2023.

Who are the main investors in Graviton BioScience?

Key investors in Graviton BioScience include Enavate Sciences.

Will Graviton BioScience IPO soon?

No public IPO plans have been announced for Graviton BioScience.

How can I track Graviton BioScience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Graviton BioScience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range31
Year Founded2020
Last FundingFeb 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?